Article Versions Notes

Lorent D, Nowak R, Roxo C, Lenartowicz E, Makarewicz A, Zaremba B, Nowak S, Kuszel L, Stefaniak J, Kierzek R, et al. Prevalence of Anti-SARS-CoV-2 Antibodies in Poznań, Poland, after the First Wave of the COVID-19 Pandemic. Vaccines. 2021; 9(6):541. https://doi.org/10.3390/vaccines9060541

Lorent, Dagny, Rafal Nowak, Carolina Roxo, Elzbieta Lenartowicz, Aleksandra Makarewicz, Bartosz Zaremba, Szymon Nowak, Lukasz Kuszel, Jerzy Stefaniak, Ryszard Kierzek, and et al. 2021. "Prevalence of Anti-SARS-CoV-2 Antibodies in Poznań, Poland, after the First Wave of the COVID-19 Pandemic" Vaccines 9, no. 6: 541. https://doi.org/10.3390/vaccines9060541

Lorent, D., Nowak, R., Roxo, C., Lenartowicz, E., Makarewicz, A., Zaremba, B., Nowak, S., Kuszel, L., Stefaniak, J., Kierzek, R., & Zmora, P. (2021). Prevalence of Anti-SARS-CoV-2 Antibodies in Poznań, Poland, after the First Wave of the COVID-19 Pandemic. Vaccines, 9(6), 541. https://doi.org/10.3390/vaccines9060541